Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts Locksley Resources LimitedLt. Gen.Schwartz to Advance US Defense Strategy December 15, 2025 Uranium Price Forecast: Top Trends for Uranium in 2026 December 15, 2025 InMed Provides Update on BayMedica Commercial Business December 13, 2025